Royal Bank of Canada’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $645M | Sell |
8,984,614
-276,841
| -3% | -$21.3M | 0.11% | 173 |
|
|
2025
Q4 | $735M | Buy |
9,261,455
+1,250,897
| +16% | +$98.6M | 0.12% | 159 |
|
|
2025
Q3 | $604M | Buy |
8,010,558
+31,705
| +0.4% | +$2.17M | 0.1% | 185 |
|
|
2025
Q2 | $550M | Sell |
7,978,853
-414,852
| -5% | -$27.2M | 0.1% | 188 |
|
|
2025
Q1 | $569M | Sell |
8,393,705
-1,588,316
| -16% | -$95M | 0.12% | 164 |
|
|
2024
Q4 | $448M | Sell |
9,982,021
-895,538
| -8% | -$50.2M | 0.09% | 208 |
|
|
2024
Q3 | $684M | Buy |
10,877,559
+1,359,906
| +14% | +$79.3M | 0.14% | 139 |
|
|
2024
Q2 | $562M | Sell |
9,517,653
-1,851,924
| -16% | -$116M | 0.13% | 147 |
|
|
2024
Q1 | $907M | Sell |
11,369,577
-906,391
| -7% | -$69.2M | 0.21% | 95 |
|
|
2023
Q4 | $969M | Sell |
12,275,968
-1,860,952
| -13% | -$132M | 0.23% | 88 |
|
|
2023
Q3 | $987M | Buy |
14,136,920
+305,112
| +2% | +$21.6M | 0.27% | 80 |
|
|
2023
Q2 | $956M | Buy |
13,831,808
+468,346
| +4% | +$33.3M | 0.25% | 85 |
|
|
2023
Q1 | $993M | Sell |
13,363,462
-633,038
| -5% | -$53.1M | 0.28% | 75 |
|
|
2022
Q4 | $1.3B | Buy |
13,996,500
+147,752
| +1% | +$14.3M | 0.37% | 58 |
|
|
2022
Q3 | $1.32B | Sell |
13,848,748
-101,747
| -0.7% | -$10.1M | 0.42% | 46 |
|
|
2022
Q2 | $1.29B | Sell |
13,950,495
-790,274
| -5% | -$77.1M | 0.38% | 53 |
|
|
2022
Q1 | $1.49B | Sell |
14,740,769
-417,955
| -3% | -$43.9M | 0.37% | 48 |
|
|
2021
Q4 | $1.56B | Buy |
15,158,724
+1,035,313
| +7% | +$95.7M | 0.36% | 56 |
|
|
2021
Q3 | $1.2B | Sell |
14,123,411
-285,735
| -2% | -$23.9M | 0.32% | 63 |
|
|
2021
Q2 | $1.2B | Sell |
14,409,146
-1,543,380
| -10% | -$126M | 0.32% | 61 |
|
|
2021
Q1 | $1.2B | Sell |
15,952,526
-2,609,272
| -14% | -$190M | 0.35% | 57 |
|
|
2020
Q4 | $1.27B | Buy |
18,561,798
+1,692,544
| +10% | +$110M | 0.37% | 54 |
|
|
2020
Q3 | $985M | Buy |
16,869,254
+2,538,609
| +18% | +$158M | 0.35% | 61 |
|
|
2020
Q2 | $931M | Buy |
14,330,645
+1,181,171
| +9% | +$74.4M | 0.37% | 57 |
|
|
2020
Q1 | $780M | Buy |
13,149,474
+554,520
| +4% | +$37M | 0.38% | 57 |
|
|
2019
Q4 | $936M | Buy |
12,594,954
+94,140
| +0.8% | +$6.61M | 0.34% | 64 |
|
|
2019
Q3 | $788M | Buy |
12,500,814
+2,591,208
| +26% | +$154M | 0.31% | 66 |
|
|
2019
Q2 | $540M | Buy |
9,909,606
+1,442,829
| +17% | +$77.7M | 0.22% | 95 |
|
|
2019
Q1 | $457M | Buy |
8,466,777
+662,054
| +8% | +$40.9M | 0.2% | 109 |
|
|
2018
Q4 | $511M | Buy |
7,804,723
+1,314,338
| +20% | +$98.1M | 0.25% | 81 |
|
|
2018
Q3 | $512M | Buy |
6,490,385
+1,939,997
| +43% | +$139M | 0.21% | 95 |
|
|
2018
Q2 | $293M | Buy |
4,550,388
+37,485
| +0.8% | +$2.47M | 0.13% | 140 |
|
|
2018
Q1 | $281M | Buy |
4,512,903
+757,032
| +20% | +$54.3M | 0.13% | 139 |
|
|
2017
Q4 | $272M | Buy |
3,755,871
+61,473
| +2% | +$4.47M | 0.12% | 151 |
|
|
2017
Q3 | $300M | Sell |
3,694,398
-569,772
| -13% | -$45.1M | 0.14% | 132 |
|
|
2017
Q2 | $343M | Sell |
4,264,170
-334,654
| -7% | -$26.4M | 0.18% | 107 |
|
|
2017
Q1 | $361M | Sell |
4,598,824
-397,044
| -8% | -$31.7M | 0.19% | 93 |
|
|
2016
Q4 | $394M | Sell |
4,995,868
-729,096
| -13% | -$59M | 0.21% | 80 |
|
|
2016
Q3 | $509M | Buy |
5,724,964
+29,292
| +0.5% | +$2.76M | 0.29% | 63 |
|
|
2016
Q2 | $545M | Sell |
5,695,672
-395,650
| -6% | -$39.4M | 0.32% | 54 |
|
|
2016
Q1 | $632M | Buy |
6,091,322
+837,959
| +16% | +$81.5M | 0.39% | 43 |
|
|
2015
Q4 | $514M | Buy |
5,253,363
+2,013,997
| +62% | +$197M | 0.34% | 52 |
|
|
2015
Q3 | $313M | Sell |
3,239,366
-628,302
| -16% | -$66.1M | 0.23% | 68 |
|
|
2015
Q2 | $406M | Buy |
3,867,668
+81,612
| +2% | +$8.34M | 0.28% | 55 |
|
|
2015
Q1 | $391M | Buy |
3,786,056
+54,875
| +1% | +$5.55M | 0.27% | 57 |
|
|
2014
Q4 | $359M | Buy |
3,731,181
+175,054
| +5% | +$15.4M | 0.23% | 69 |
|
|
2014
Q3 | $283M | Buy |
3,556,127
+150,361
| +4% | +$11.9M | 0.19% | 83 |
|
|
2014
Q2 | $257M | Sell |
3,405,766
-86,355
| -2% | -$6.53M | 0.17% | 84 |
|
|
2014
Q1 | $261M | Buy |
3,492,121
+421,725
| +14% | +$29.8M | 0.19% | 76 |
|
|
2013
Q4 | $220M | Buy |
3,070,396
+751,125
| +32% | +$48.3M | 0.16% | 97 |
|
|
2013
Q3 | $132M | Sell |
2,319,271
-1,040,583
| -31% | -$62M | 0.1% | 141 |
|
|
2013
Q2 | $192M | Buy |
+3,359,854
| New | +$195M | 0.16% | 89 |
|
Other funds holding CVS
VCM
VPM
Royal Bank of Canada's CVS Position: Q1 2026 in Review
Royal Bank of Canada reduced its CVS Health (CVS) stake by 3% in Q1 2026, selling an estimated $21.3M and leaving 8,984,614 shares worth $645M. The position accounts for 0.11% of the portfolio, ranked #173.
Royal Bank of Canada first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.56B in Q4 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Royal Bank of Canada held 8,984,614 shares of CVS Health worth $645M as of Q1 2026.
- Royal Bank of Canada sold 276,841 CVS Health shares in Q1 2026, an estimated $21.3M.
- CVS Health made up 0.11% of Royal Bank of Canada's portfolio in Q1 2026, its #173 holding.
- Royal Bank of Canada first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's CVS Health position peaked at $1.56B in Q4 2021.
- 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.